| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/15/2004 | WO2001070955A8 Identification of essential genes in prokaryotes |
| 04/15/2004 | WO2001019852A8 Methods of peptide preparation |
| 04/15/2004 | US20040073958 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040073008 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/15/2004 | US20040073000 Genes and proteins, and their uses |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders |
| 04/15/2004 | US20040072892 Dipeptidyl aminopeptidase inhibitors; kidney and liver disorders; autoimmune diseases; antiarthritic agents; psoriasis; anticancer agents |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072873 Therapy for drug resistant infections |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072859 Urea substituted imidazoquinoline ethers |
| 04/15/2004 | US20040072858 Heterocyclic ether substituted imidazoquinolines |
| 04/15/2004 | US20040072853 Therapeutic compounds |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072846 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 04/15/2004 | US20040072842 Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent |
| 04/15/2004 | US20040072841 Topical administration of oxazolidinones for transdermal delivery |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072791 Method for producing pectin hydrolysis products |
| 04/15/2004 | US20040072788 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/15/2004 | US20040072780 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 04/15/2004 | US20040072779 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 04/15/2004 | US20040072771 Ex vivo gene therapy; HIV infection; at least 1.63 x 106 CD34+ hematopoietic cells (per kg of body weight) being transduced with a viral construct which expresses an anti-HIV agent |
| 04/15/2004 | US20040072761 Heterocyclicsulfonamide hepatitis C virus inhibitors |
| 04/15/2004 | US20040072748 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
| 04/15/2004 | US20040072738 Analogues of thiocoraline and be-22179 |
| 04/15/2004 | US20040072737 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents |
| 04/15/2004 | US20040072340 Use of peptide vectors to improve the immune response to antigens |
| 04/15/2004 | US20040072299 Multiple cytokine protein complexes |
| 04/15/2004 | US20040072256 Nk cells activiating receptors and their therapeutic and diagnostic uses |
| 04/15/2004 | US20040072240 Identifying cryptic epitopes comprising amino acid sequences of tumor antigen for diagnosis and treatment of viral and cancer disorder; viricides; antitumor agents |
| 04/15/2004 | US20040072206 Screening for enzyme inhibitor to prevent microorganismal propagation; bactericides; antibiotic |
| 04/15/2004 | US20040072168 Novel deoxynucleoside kinase enzyme variants |
| 04/15/2004 | US20040072162 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 04/15/2004 | US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 04/15/2004 | US20040071790 Ayurvedic formulation for treating acquired immune deficiency syndrome (HIV/AIDS) patients to obtain negative results of HIV/AIDS infection & other dreaded diseases and process for preparing the same |
| 04/15/2004 | US20040071734 Novel vaccine |
| 04/15/2004 | US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 04/15/2004 | US20040071730 Polypeptides and polynucleotides; genetic engineering; medical diagnosis |
| 04/15/2004 | US20040071713 A protein is obtained from gene expression of Pseudomonas aeruginosa, molecular weight range from 13 kDa to 80 kDa, purification, antibody, immunization with vaccine antigens, treating bacterial infections |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071691 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity |
| 04/15/2004 | US20040071663 Pesticidal and antiparasitic compositions |
| 04/15/2004 | US20040071656 Modulation of heat-shock-protein-based immunotherapies |
| 04/15/2004 | US20040071655 Binding agent |
| 04/15/2004 | US20040071654 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 04/15/2004 | CA2500960A1 Therapeutic uspa1-derived peptides |
| 04/15/2004 | CA2500955A1 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | CA2500716A1 Compositions comprising highly purified amphotericin b |
| 04/15/2004 | CA2500433A1 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/15/2004 | CA2500413A1 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 04/15/2004 | CA2500401A1 Antigenic peptides |
| 04/15/2004 | CA2500259A1 Potent inhibitor of hcv serine protease |
| 04/14/2004 | EP1408110A2 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 04/14/2004 | EP1408034A1 Use of Quinoline derivatives as antibacterial agents |
| 04/14/2004 | EP1408031A1 Pyrolidine derivatives useful in treatment of hepatitis C virus infection |
| 04/14/2004 | EP1408028A1 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 04/14/2004 | EP1407275A2 Use of transcription factor nak-1 or genes regulated by transcription factor nak-1 for the diagnosis and/or therapy of inflammatory and malignant diseases |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1407033A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 04/14/2004 | EP1407023A2 Group b streptococcus antigens and corresponding dna fragments |
| 04/14/2004 | EP1407008A2 Influenza vaccine composition |
| 04/14/2004 | EP1407007A1 Attenuated circovirus |
| 04/14/2004 | EP1406998A2 Liver engrafting cells, assays, and uses thereof |
| 04/14/2004 | EP1406928A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2004 | EP1406914A2 Porphyrin derivatives for photodynamic therapy |
| 04/14/2004 | EP1406911A1 6-[2-(phosphonomethoxy)alkoxy]pyrimidine derivatives having antiviral activity |
| 04/14/2004 | EP1406910A1 Novel bisphosphonate derivatives, their preparation methods and uses |
| 04/14/2004 | EP1406901A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 04/14/2004 | EP1406899A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 04/14/2004 | EP1406895A1 Lactone formulations and method of use |
| 04/14/2004 | EP1406893A1 Pyrrolidine bicyclic compounds |
| 04/14/2004 | EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 04/14/2004 | EP1406880A1 Crystalline thiazine oxazolidinones |
| 04/14/2004 | EP1406878A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 04/14/2004 | EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/14/2004 | EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406867A2 Thiolalkyl benzoic acid derivatives |
| 04/14/2004 | EP1406866A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/14/2004 | EP1406700A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 04/14/2004 | EP1406667A2 METHODS FOR INCREASING i IN VIVO /i EFFICACY OF OLIGONUCLEOTIDES AND INHIBITING INFLAMMATION IN MAMMALS |
| 04/14/2004 | EP1406664A2 Targeting chemical compounds to cells |
| 04/14/2004 | EP1406660A1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 04/14/2004 | EP1406659A1 Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof |
| 04/14/2004 | EP1406656A2 METHODS OF ADMINISTERING ANTI-TNF$g(a) ANTIBODIES |
| 04/14/2004 | EP1406654A2 Methods for regulating bacteria |
| 04/14/2004 | EP1406650A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |
| 04/14/2004 | EP1406642A2 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 04/14/2004 | EP1406640A2 Use of glycosaminoglycans for the treatment of hiv-associated nephropathy |
| 04/14/2004 | EP1406632A2 Substituted 3-aryl-5-aryl- 1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406619A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 04/14/2004 | EP1406616A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |